Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease Ilja M. Blok, Annelieke C.M.J. van.
Pulmonary hypertension
Hemodynamic classification of pulmonary hypertension (PH)
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 
REVEAL Registry PAH Risk Score Calculator
Pulmonary arterial hypertension due to pulmonary veno-occlusive disease in systemic sclerosis: Importance of early diagnosis and cautious use of pulmonary.
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Volume 141, Issue 2, Pages (February 2012)
A Framework for Diagnosing and Treating CTEPH
Update on the Diagnosis and Management of CTEPH in Latin America
Meghan E. Sise, Andrew M. Courtwright, Richard N. Channick 
by Victor R. Gordeuk, Oswaldo L. Castro, and Roberto F. Machado
New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery  Stephen.
Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension  Laurent Savale, MD, PhD, Jérôme Le Pavec, MD, PhD,
H M M IF Causes of Pulmonary Hypertension in Patients with Sarcoid Perivascular fibrosis Increased vasoreactivity Granulomas in pulmonary.
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
From the Feds: Research, programs, and products
Successful Surgical Management of Invasive Aspergillosis of the Pulmonary Arteries  Giorgio Zanotti, MD, Salvatore Nicolardi, MD, Marco Morsolini, MD,
Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic.
ECG: electrocardiogram; PFT: pulmonary function testing; Dlco: diffusion capacity of the lung for carbon monoxide; BGA: blood gas analysis; HRCT: high-resolution.
Diagnostic algorithm for pulmonary arterial hypertension (PAH).
Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study  C.A. Rushton, U.T. Kadam  International.
Tricuspid annular plane systolic excursion (TAPSE) in pediatric pulmonary hypertension: Integrating right ventricular ejection efficiency (RVEe) into.
Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.
Volume 146, Issue 6, Pages (December 2014)
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the.
Pulmonary Hypertension Updates From 2018
Diagnostic algorithm. Diagnostic algorithm. PH: pulmonary hypertension; group: clinical group; TTE: transthoracic echocardiography; PFT: pulmonary function.
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018  Heinrike Wilkens, Stavros Konstantinides,
Algorithm for the diagnosis and treatment of portopulmonary hypertension (POPH). Algorithm for the diagnosis and treatment of portopulmonary hypertension.
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018  Marius M. Hoeper, Christian Apitz,
REVEAL pulmonary arterial hypertension (PAH) risk score.
Michael D. McGoon, MD, Abby Krichman, RRT, Harrison W
Pulmonary hypertension in adults with congenital heart disease: Updated recommendations from the Cologne Consensus Conference 2018  Harald Kaemmerer,
Inclusion characteristics of a) previously diagnosed and b) newly diagnosed pulmonary arterial hypertension (PAH) patients enrolled in REVEAL. PVR: pulmonary.
Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018  Stephan Rosenkranz, Irene.
An algorithm for the early diagnosis of pulmonary arterial hypertension in systemic sclerosis. An algorithm for the early diagnosis of pulmonary arterial.
Symptoms Are More Useful Than Echocardiography in Patient Selection for Pulmonary Endarterectomy  Laura Donahoe, MD, Rachel Vanderlaan, MD, John Thenganatt,
International Journal of Cardiology
Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012  A.C.E.
Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary.
Update in preoperative risk assessment in vascular surgery patients
Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations  Willem J. Verberk, Stefano.
International Journal of Cardiology
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
Selection of patients: 248 consecutive patients with newly diagnosed pre-capillary pulmonary hypertension were included in the study. Selection of patients:
Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression  Corline Brouwers, Stefan.
Micha T. Maeder, MD, PhD, Niklas F. Ehl, MD 
General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018  Ekkehard.
Simplified REVEAL (Registry to Evaluate Early And Long-term PAH Disease Management) risk score. Simplified REVEAL (Registry to Evaluate Early And Long-term.
Proposed screening algorithm for identification of pulmonary arterial hypertension (PAH) associated with connective tissue disease. Proposed screening.
Reviewer Acknowledgment
International Journal of Cardiology
Clinical Comparisons in CTEPH
Mean change from baseline in 6MWD in (A) Chinese patients with PAH in PATENT-1 and (B) Chinese patients with CTEPH in CHEST-1. Mean change from baseline.
Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension  Johannes M. Douwes, Marcus T.R. Roofthooft,
Cologne consensus conference on pulmonary hypertension – Update 2018
Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese  XiaoMin Yang, MD, Kai Sun, PhD, WeiLi.
Distribution of mutations in sporadic and familial pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary.
Definition of pulmonary hypertension (PH) associated with left heart disease. mPAP: mean pulmonary arterial pressure; PAWP: pulmonary artery wedge pressure;
A) Pulmonary arterial hypertension (PAH) aetiological breakdown of REVEAL patients at enrolment. b) Breakdown of associated PAH subgroup. a) Pulmonary.
Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm,
Algorithm for haemodynamic evaluation in the elderly.
Distribution of diffusing capacity of the lung for carbon monoxide (DLCO) among 243 scleroderma patients who underwent right heart catheterisation (RHC)
Diagnostic algorithm for chronic thromboembolic pulmonary hypertension
Module 2: evaluation of the REVEAL risk score in the FPHN validation cohort. Module 2: evaluation of the REVEAL risk score in the FPHN validation cohort.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Presentation transcript:

Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018  Gabor Kovacs, Daniel Dumitrescu, Andreas Barner, Sebastian Greiner, Ekkehard Grünig, Alfred Hager, Thomas Köhler, Rainer Kozlik- Feldmann, Irmtraut Kruck, Astrid E. Lammers, Derliz Mereles, Andreas Meyer, Joachim Meyer, Stefan Pabst, Hans-Jürgen Seyfarth, Christoph Sinning, Stephan Sorichter, Gerd Stähler, Heinrike Wilkens, Matthias Held  International Journal of Cardiology  Volume 272, Pages 11-19 (December 2018) DOI: 10.1016/j.ijcard.2018.08.083 Copyright © 2018 Terms and Conditions

Fig. 1 Proposed diagnostic algorithm in case of suspected pulmonary hypertension, according to the 2016 Cologne Consensus Conference (modified from Ref. [1]). ⁎PAH, differentiation of typical/atypical PAH. aIn case of echocardiographic evidence of PH, even in patients who show signs of PH due to left heart or lung disease according to tests, an exclusion of CTEPH by scintigraphy should be considered in the presence of typical risk factors for CTEPH. bIn case of echocardiographic evidence of PH, even in patients who show signs of PH due to left heart or lung disease according to tests, consultation with a PH expert centre should be considered in the presence of risk factors for PAH if there is uncertainty as to whether these constitute a cause or comorbidity. PH: pulmonary hypertension, CTEPH: chronic thromboembolic pulmonary hypertension, DLCO: diffusing capacity for carbon monoxide, PAH: pulmonary arterial hypertension, PVOD: pulmonary veno-occlusive disease, PCH: pulmonary capillary haemangiomatosis, mPAP: mean pulmonary arterial pressure, PAWP: pulmonary arterial Wedge pressure, PVR: pulmonary vascular resistance. Original version from Ref. [1]. International Journal of Cardiology 2018 272, 11-19DOI: (10.1016/j.ijcard.2018.08.083) Copyright © 2018 Terms and Conditions